Two new oral antivirals for covid-19: ▼molnupiravir and ▼nirmatrelvir plus ritonavir

Overview of attention for article published in Drug & Therapeutics Bulletin, April 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#30 of 817)
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 2 news outlets
twitter: 16 tweeters

facebook: 1 Facebook page

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 18 Mendeley

Summary News Twitter Facebook Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Saline nasal irrigation and gargling in COVID-19: a multidisciplinary review of effects on viral load, mucosal dynamics, and patient outcomes

Article in Frontiers in Public Health (June 2023)

Molnupiravir provides little benefit in vaccinated adults with COVID-19

Article in Drug and Therapeutics Bulletin (April 2023)

Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform

Article in The BMJ (November 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.